Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borja Quiroga

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Clinical Kidney Journal|August 24, 2022
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT RegistryBorja Quiroga, Alberto Ortiz, Carlos Jesús Cabezas-Reina, et al.
Nefrologia|November 24, 2023
Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of NephrologyFabiola Alonso, Ángel L M Martín de Francisco, Pilar Auñón, et al.
Nefrologia|September 5, 2017
Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney massIsabel Galán, Marian Goicoechea, Borja Quiroga, et al.
Metabolites|November 25, 2021
Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric StudyPatricia Muñoz Ramos, Yohana Gil Giraldo, Vicente Álvarez-Chiva, et al.
Nefrologia|July 7, 2026
Position statement of the SEN Anemia Working Group: A critical and contextualized adaptation of the KDIGO 2026 anemia guidelines to the Spanish settingJose Portolés, Elisabeth Coll, M Jesús Puchades, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 9, 2017
Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patientsMarian Goicoechea, Maria Dolores Sanchez-Niño, Alberto Ortiz, et al.
Blood Purification|July 7, 2025
Influence of Different Hemodialysis Biocontrols on the Achievement of the Convective VolumePatricia Muñoz Ramos, Laura Guasch, David Conejo, et al.
Journal of the American Society of Hypertension : JASH|April 22, 2014
Clinical determinants and prognostic significance of the electrocardiographic strain pattern in chronic kidney disease patientsAntonio C Cordeiro, Aline A I Moraes, Virginia Cerutti, et al.
Kidney Diseases (Basel, Switzerland)|July 27, 2023
Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language ProcessingAlberto Ortiz, Jose Portoles, Maria Dolores Pino-Pino, et al.
Cardiovascular Drugs and Therapy|June 27, 2018
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)Marian Goicoechea, Soledad García de Vinuesa, Borja Quiroga, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Clinical Kidney Journal|August 24, 2022
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT RegistryBorja Quiroga, Alberto Ortiz, Carlos Jesús Cabezas-Reina, et al.
Nefrologia|November 24, 2023
Adverse renal effects of check-point inhibitors (ICI) in cancer patients: Recommendations of the Onco-nephrology Working Group of the Spanish Society of NephrologyFabiola Alonso, Ángel L M Martín de Francisco, Pilar Auñón, et al.
Nefrologia|September 5, 2017
Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney massIsabel Galán, Marian Goicoechea, Borja Quiroga, et al.
Metabolites|November 25, 2021
Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric StudyPatricia Muñoz Ramos, Yohana Gil Giraldo, Vicente Álvarez-Chiva, et al.
Nefrologia|July 7, 2026
Position statement of the SEN Anemia Working Group: A critical and contextualized adaptation of the KDIGO 2026 anemia guidelines to the Spanish settingJose Portolés, Elisabeth Coll, M Jesús Puchades, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 9, 2017
Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patientsMarian Goicoechea, Maria Dolores Sanchez-Niño, Alberto Ortiz, et al.
Blood Purification|July 7, 2025
Influence of Different Hemodialysis Biocontrols on the Achievement of the Convective VolumePatricia Muñoz Ramos, Laura Guasch, David Conejo, et al.
Journal of the American Society of Hypertension : JASH|April 22, 2014
Clinical determinants and prognostic significance of the electrocardiographic strain pattern in chronic kidney disease patientsAntonio C Cordeiro, Aline A I Moraes, Virginia Cerutti, et al.
Kidney Diseases (Basel, Switzerland)|July 27, 2023
Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language ProcessingAlberto Ortiz, Jose Portoles, Maria Dolores Pino-Pino, et al.
Cardiovascular Drugs and Therapy|June 27, 2018
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)Marian Goicoechea, Soledad García de Vinuesa, Borja Quiroga, et al.
Pageof 14